CN106115792A - A method for preparing Fe2O3 nanoparticles with collagen as biomineralization template - Google Patents
A method for preparing Fe2O3 nanoparticles with collagen as biomineralization template Download PDFInfo
- Publication number
- CN106115792A CN106115792A CN201610458525.9A CN201610458525A CN106115792A CN 106115792 A CN106115792 A CN 106115792A CN 201610458525 A CN201610458525 A CN 201610458525A CN 106115792 A CN106115792 A CN 106115792A
- Authority
- CN
- China
- Prior art keywords
- collagen
- temperature
- preparation
- protein
- template
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 61
- 108010035532 Collagen Proteins 0.000 title claims abstract description 61
- 229920001436 collagen Polymers 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000033558 biomineral tissue development Effects 0.000 title claims abstract description 20
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 17
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 title description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 claims abstract description 15
- 239000002086 nanomaterial Substances 0.000 claims abstract description 15
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 10
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 10
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 10
- 238000000746 purification Methods 0.000 claims abstract description 9
- 238000001027 hydrothermal synthesis Methods 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 6
- 238000005516 engineering process Methods 0.000 claims abstract description 4
- 239000007787 solid Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- 241000894006 Bacteria Species 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 238000005119 centrifugation Methods 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 8
- 239000013612 plasmid Substances 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002609 medium Substances 0.000 claims description 7
- 235000019750 Crude protein Nutrition 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000012460 protein solution Substances 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 229910003145 α-Fe2O3 Inorganic materials 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 2
- 230000003115 biocidal effect Effects 0.000 claims 2
- 229960002897 heparin Drugs 0.000 claims 2
- 229920000669 heparin Polymers 0.000 claims 2
- 238000010792 warming Methods 0.000 claims 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 239000006227 byproduct Substances 0.000 claims 1
- 239000012531 culture fluid Substances 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000008240 homogeneous mixture Substances 0.000 claims 1
- 150000002460 imidazoles Chemical class 0.000 claims 1
- 102000006495 integrins Human genes 0.000 claims 1
- 108010044426 integrins Proteins 0.000 claims 1
- 210000002429 large intestine Anatomy 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 210000002706 plastid Anatomy 0.000 claims 1
- 238000010257 thawing Methods 0.000 claims 1
- 230000009466 transformation Effects 0.000 claims 1
- 229910000859 α-Fe Inorganic materials 0.000 abstract description 22
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- 229940044631 ferric chloride hexahydrate Drugs 0.000 abstract description 10
- 238000003786 synthesis reaction Methods 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 7
- 239000011259 mixed solution Substances 0.000 abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000000243 solution Substances 0.000 description 7
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229940032296 ferric chloride Drugs 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 238000000026 X-ray photoelectron spectrum Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000002411 thermogravimetry Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002003 electron diffraction Methods 0.000 description 1
- 239000012776 electronic material Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003837 high-temperature calcination Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- -1 tissue engineering Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/06—Ferric oxide [Fe2O3]
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/85—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by XPS, EDX or EDAX data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/88—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by thermal analysis data, e.g. TGA, DTA, DSC
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/03—Particle morphology depicted by an image obtained by SEM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种以胶原蛋白为生物矿化模板制备Fe2O3纳米粒子的方法,包括如下步骤:(1)利用生物基因工程技术制备重组胶原蛋白:①、确定重组胶原蛋白的序列;②、合成编码重组胶原蛋白的核酸;③、重组胶原蛋白的制备与纯化;(2)α‑Fe2O3纳米材料的制备:①、重组胶原蛋白与六水合三氯化铁均匀混合溶液的配制;②、利用水热反应釜制备纳米级α‑Fe2O3;③、纯化并干燥保存制备的纳米材料。本发明采用重组胶原蛋白作为生物模板,六水合三氯化铁作为原料,通过水热方法,制备了大小和形貌可控的α‑Fe2O3纳米材料。本发明在整个合成过程中无需添加任何其他化学试剂或进行后处理,简单方便,易于操作,具有很大的应用前景,可为规模化生产α‑Fe2O3纳米材料提供基础。
The invention discloses a method for preparing Fe 2 O 3 nanoparticles by using collagen as a biomineralization template, comprising the following steps: (1) preparing recombinant collagen by using biogenetic engineering technology: ①, determining the sequence of recombinant collagen; ②. Synthesis of nucleic acid encoding recombinant collagen; ③. Preparation and purification of recombinant collagen; (2) Preparation of α-Fe 2 O 3 nanomaterials: ①. Preparation of a uniform mixed solution of recombinant collagen and ferric chloride hexahydrate Preparation; ②, using a hydrothermal reactor to prepare nano-scale α-Fe 2 O 3 ; ③, purifying and drying the prepared nano-material. In the present invention, recombinant collagen is used as a biological template, ferric chloride hexahydrate is used as a raw material, and α-Fe 2 O 3 nanometer materials with controllable size and shape are prepared through a hydrothermal method. The invention does not need to add any other chemical reagents or perform post-treatment during the whole synthesis process, is simple, convenient, easy to operate, has great application prospects, and can provide a basis for large-scale production of α-Fe 2 O 3 nanometer materials.
Description
技术领域technical field
本发明涉及Fe2O3纳米粒子制备方法,具体涉及一种以胶原蛋白为生物矿化模板制备Fe2O3纳米粒子的方法,属于生物无机材料制备技术领域。 The invention relates to a method for preparing Fe2O3 nanoparticles, in particular to a method for preparing Fe2O3 nanoparticles by using collagen as a biomineralization template, and belongs to the technical field of bioinorganic material preparation.
背景技术Background technique
生物矿化是指生物体通过生物大分子的调控作用生成无机矿物质的过程,它是链接无机与生物之间的桥梁。与一般矿化最大的不同在于,它是生物在特定的部位,在一定的物理化学条件下,在生物有机物质的参与控制或影响下,将溶液中的离子转变为固相矿物的过程。像骨骼,鳞片,牙齿等的形成都是自然界中比较常见的生物矿化过程。与工业生产条件不同,生物矿化不需要苛刻的条件,它是一个条件温和、低耗能且无污染的物理化学过程。生物矿化采用了自然界中比较简单且常见的组分,并且可以实现对样品从成核到结晶过程的调控。因此,探索并模仿生物矿化中无机物在生物分子调控下的矿化机理,能为制备具有独特结构和性能的复合材料提供新的视角。Biomineralization refers to the process in which organisms generate inorganic minerals through the regulation of biological macromolecules. It is a bridge between inorganic and biological. The biggest difference from general mineralization is that it is a process in which organisms transform ions in solution into solid-phase minerals at specific locations, under certain physical and chemical conditions, and under the control or influence of biological organic substances. The formation of bones, scales, teeth, etc. are relatively common biomineralization processes in nature. Unlike industrial production conditions, biomineralization does not require harsh conditions. It is a physical and chemical process with mild conditions, low energy consumption and no pollution. Biomineralization uses relatively simple and common components in nature, and can realize the regulation of the sample from nucleation to crystallization. Therefore, exploring and simulating the mineralization mechanism of inorganic substances under the regulation of biomolecules in biomineralization can provide a new perspective for the preparation of composite materials with unique structures and properties.
α型三氧化二铁(α-Fe2O3)是一种很重要的金属氧化物,由于其无毒,无环境污染,成本低廉等特点,在闪光涂料、塑料、电子材料以及生物医学工程等方面都有广泛的应用。现在已经建立了α-Fe2O3纳米材料的多种合成方法,包括:(1)使用三氯化铁和草酸为原料首先合成氧化铁的初级结构,然后再通过高温锻烧合成中空的梭形和球形结构α-Fe2O3;(2)使用三氯化铁和四丁基漠化钱在碱性条件下,经过后处理制备花状α-Fe2O3纳米结构。这些方法有的需要在合成过程中添加有毒有害的化学试剂,有的需要经过升温去除溶剂或摸板等后处理才能得到产物,都相对比较复杂,并且存在耗时耗能和成本较高的缺点。同时,由于目前对α-Fe2O3纳米颗粒形貌和尺寸可控性的基础研究仍不够系统和充分,因此为满足不同需求,采用简单、易控、绿色环保的方法来调控α-Fe2O3纳米颗粒的形貌和尺寸具有十分重要的意义。α-type ferric oxide (α-Fe 2 O 3 ) is a very important metal oxide. Due to its non-toxic, non-environmental pollution and low cost, it is widely used in flash coatings, plastics, electronic materials and biomedical engineering. and so on have a wide range of applications. A variety of synthesis methods for α-Fe 2 O 3 nanomaterials have been established, including: (1) using ferric chloride and oxalic acid as raw materials to first synthesize the primary structure of iron oxide, and then synthesize the hollow shuttle by high-temperature calcination Shaped and spherical structure α-Fe 2 O 3 ; (2) The flower-like α-Fe2O3 nanostructure was prepared by post-treatment using ferric chloride and tetrabutylcolumnium bromide under alkaline conditions. Some of these methods need to add toxic and harmful chemical reagents in the synthesis process, and some need to go through post-processing such as heating up to remove solvents or templates to obtain products, which are relatively complicated, and have the disadvantages of time-consuming, energy-consuming and high cost. . At the same time, since the current basic research on the shape and size controllability of α-Fe 2 O 3 nanoparticles is still not systematic and sufficient, in order to meet different needs, a simple, easy-to-control, and green method is used to regulate α-Fe 2 O 3 The shape and size of 2 O 3 nanoparticles are very important.
胶原蛋白是细胞外基质的主要组成成分,几乎分布在所有的组织器官中,它在哺乳动物中含量高达总蛋白量的四分之一。胶原蛋白具有良好的生物相容性,生物降解性,吸收性以及促进细胞形成等诸多功能,因此,在生物医用材料、组织工程、化妆品、食品等领域具有广泛的应用。本发明采用重组胶原蛋白作为生物模板,六水合三氯化铁作为原料,通过水热方法,制备了大小和形貌可控的α-Fe2O3纳米材料。本发明在整个合成过程中无需添加任何其他化学试剂或进行后处理,简单方便,易于操作,具有相当的可行性和应用价值,可为规模化生产α-Fe2O3纳米材料提供基础。Collagen is the main component of the extracellular matrix, distributed in almost all tissues and organs, and its content is as high as a quarter of the total protein in mammals. Collagen has many functions such as good biocompatibility, biodegradability, absorption and promotion of cell formation, so it has a wide range of applications in biomedical materials, tissue engineering, cosmetics, food and other fields. The invention adopts recombinant collagen as a biological template, ferric chloride hexahydrate as a raw material, and prepares α-Fe 2 O 3 nanometer materials with controllable size and shape through a hydrothermal method. The invention does not need to add any other chemical reagents or perform post-treatment during the whole synthesis process, is simple, convenient, easy to operate, has considerable feasibility and application value, and can provide a basis for large-scale production of α-Fe 2 O 3 nanometer materials.
发明内容Contents of the invention
本发明的目的是针对现有技术中的不足,提供一种以胶原蛋白为生物矿化模板制备Fe2O3纳米粒子的方法,采用动物体内含量最多的蛋白质胶原蛋白作为生物模板,六水合三氯化铁作为原料,通过水热方法,制备了大小和形貌可控的α-Fe2O3纳米材料。 The purpose of the present invention is to address the deficiencies in the prior art and provide a method for preparing Fe2O3 nanoparticles using collagen as a biomineralization template. Collagen, the most abundant protein in animals, is used as a biological template. Using ferric chloride as raw material, α-Fe 2 O 3 nanomaterials with controllable size and shape were prepared by hydrothermal method.
为实现上述目的,本发明公开了如下技术方案:To achieve the above object, the present invention discloses the following technical solutions:
一种以胶原蛋白为生物矿化模板制备Fe2O3纳米粒子的方法,包括如下步骤: A method for preparing Fe2O3 nanoparticles with collagen as biomineralization template, comprising the steps of:
(1)利用生物基因工程技术制备重组胶原蛋白(1) Preparation of recombinant collagen by biogenetic engineering technology
①、确定重组胶原蛋白的序列;①. Determine the sequence of recombinant collagen;
重组胶原蛋白的序列为:The sequence of recombinant collagen is:
GSPGLPGPRGEQGPTGPTGPAGPRGLQGLQGLQGERGEQGPTGPAGPRGLQGERGEQGPTGLAGKAGEAGAKGETGPAGPQGPRGEQGPQGLPGKDGEAGAQGRPGKRGKQGQKGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGFPGERGVEGQNGQDGLPGKDGKDGQNGKDGLPGKDGKDGQNGKDGLPGKDGKDGQDGKDGLPGKDGKDGLPGKDGKDGQPGKPGKYGPPGPPGPPGPPGPPGPPGPPGPPGPPGPP,该重组胶原蛋白具备良好的三重螺旋结构,热变温度接近37℃;具有整合素的结合位点GERGFPGERGVE,可以与细胞很好的粘附;具有肝素的结合位点GRPGKRGKQGQK,可以与肝素结合;GSPGLPGPRGEQGPTGPTGPAGPRGLQGLQGLQGERGEQGPTGPAGPRGLQGERGEQGPTGLAGKAGEAGAKGETGPAGPQGPRGEQGPQGLPGKDGEAGAQGRPGKRGKQGQKGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGFPGERGVEGQNGQDGLPGKDGKDGQNGKDGLPGKDGKDGQNGKDGLPGKDGKDGQDGKDGLPGKDGKDGLPGKDGKDGQPGKPGKYGPPGPPGPPGPPGPPGPPGPPGPPGPPGPP,该重组胶原蛋白具备良好的三重螺旋结构,热变温度接近37℃;具有整合素的结合位点GERGFPGERGVE,可以与细胞很好的粘附;具有肝素的结合位点GRPGKRGKQGQK,可以与肝素结合;
②、合成编码重组胶原蛋白的核酸;②, synthesis of nucleic acid encoding recombinant collagen;
合成编码步骤①重组胶原蛋白的核酸,构建导入上述核酸的质粒,并将质粒转化大肠杆菌BL21-DE3菌株;Synthesis of coding steps ① recombining the nucleic acid of collagen, constructing a plasmid for introducing the above nucleic acid, and transforming the plasmid into Escherichia coli BL21-DE3 strain;
③、重组胶原蛋白的制备与纯化;③. Preparation and purification of recombinant collagen;
将冰冻在-80℃的大肠杆菌感受态细胞置于冰浴中融化,将感受态细胞与3-5ul质粒混合,混合体在冰浴中30min后再放入42℃水浴中90s,然后再放入冰浴中2min;在上述混合体中加入1ml不含抗生素的LB培养基,再放置于37℃恒温摇床中1hrs,然后在4℃,4000rpm条件下离心20min,弃去上层清液;使细菌在剩余培养液中重新悬浮后,将培养液均匀涂布到37℃的AMP培养平板上,置于37℃恒温摇床中过夜培养;次日挑取长势较好的菌落放入100ml含抗生素的LB液体培养基中,恒温摇床过夜进行增菌培养;将100ml过夜培养的细菌倒入1L LB培养基中,在37℃恒温摇床中继续扩增培养;待OD值达到0.8-1范围,将摇床温度调为25℃,加入1mM IPTG诱导表达,恒温过夜培养;Thaw the E. coli competent cells frozen at -80°C in an ice bath, mix the competent cells with 3-5ul plasmid, put the mixture in the ice bath for 30min, then put it in a 42°C water bath for 90s, and then put Put it in an ice bath for 2 minutes; add 1ml of LB medium without antibiotics to the above mixture, place it in a constant temperature shaker at 37°C for 1hrs, then centrifuge at 4°C and 4000rpm for 20min, discard the supernatant; After the bacteria were resuspended in the remaining culture medium, the culture medium was evenly spread on the AMP culture plate at 37°C, and placed in a constant temperature shaker at 37°C for overnight culture; the next day, pick the colony with better growth and put it into 100ml containing antibiotics In the LB liquid culture medium, carry out the enrichment culture overnight on a constant temperature shaker; pour 100ml of overnight cultured bacteria into 1L LB medium, and continue to expand and cultivate in a constant temperature shaker at 37°C; wait until the OD value reaches the range of 0.8-1 , adjust the shaker temperature to 25°C, add 1mM IPTG to induce expression, and culture overnight at constant temperature;
将上述蛋白已表达的细菌在低温离心机中离心,使菌体与培养基分离,离心条件:12000rpm,4℃,离心1.0-3.0min;将离心后的菌体用A缓冲液溶解,A缓冲液为20mM咪唑,20mM磷酸钠,0.5M氯化钠,pH为7.4;将细菌悬浊液放入超声波细胞破碎仪中进行细胞破碎,即可释放出蛋白并且蛋白会溶于A缓冲液中;超声时需将细菌悬浊液放于冰浴中,以防温度过高导致蛋白变性;将破碎完的悬浊液再次离心,使细胞碎片与蛋白溶液分离,离心条件:14000rpm,4℃,30-50min;收集上清液,此即为粗蛋白溶液;将粗蛋白过滤后,通过液相色谱进行进一步纯化;后经冻干,得到白色絮状固体;此固体放于-20℃冰箱保存,使用时通过称重法标定浓度。Centrifuge the bacteria that have expressed the above protein in a low-temperature centrifuge to separate the bacteria from the medium. Centrifugation conditions: 12000rpm, 4°C, centrifuge for 1.0-3.0min; dissolve the centrifuged bacteria with A buffer, A buffer The liquid is 20mM imidazole, 20mM sodium phosphate, 0.5M sodium chloride, and the pH is 7.4; put the bacterial suspension into an ultrasonic cell disruptor for cell disruption, and the protein can be released and the protein will be dissolved in the A buffer; During ultrasonication, the bacterial suspension should be placed in an ice bath to prevent protein denaturation caused by excessive temperature; the broken suspension should be centrifuged again to separate the cell fragments from the protein solution. Centrifugation conditions: 14000rpm, 4°C, 30 -50min; collect the supernatant, which is the crude protein solution; filter the crude protein, and further purify it by liquid chromatography; and then freeze-dry to obtain a white flocculent solid; store the solid in a -20°C refrigerator. The concentration is calibrated by weighing method when used.
(2)α-Fe2O3纳米材料的制备(2) Preparation of α-Fe 2 O 3 nanomaterials
①、重组胶原蛋白与六水合三氯化铁均匀混合溶液的配制;①. Preparation of a uniform mixed solution of recombinant collagen and ferric chloride hexahydrate;
在1ml水中加入1-50mg六水合三氯化铁和0-10mg胶原蛋白固体,混合均匀,缓慢搅拌5-90min后,得到淡黄色透明且均匀的液体;Add 1-50mg of ferric chloride hexahydrate and 0-10mg of collagen solids in 1ml of water, mix well, and stir slowly for 5-90min to obtain a light yellow transparent and uniform liquid;
②、利用水热反应釜制备纳米级α-Fe2O3;②. Preparation of nano-scale α-Fe 2 O 3 by hydrothermal reactor;
将所得混合液倒入5ml水热反应釜中,放入马弗炉内以3-18℃/min的速度升温至120-200℃,并在该温度下反应1-15hrs;Pour the resulting mixture into a 5ml hydrothermal reaction kettle, put it into a muffle furnace and raise the temperature to 120-200°C at a rate of 3-18°C/min, and react at this temperature for 1-15hrs;
③、纯化并干燥保存制备的纳米材料;③, purifying and drying the prepared nanomaterials;
待水热反应釜冷却到室温后,将产物通过离心分离,离心条件为1200r,弃去上清液,留下固体;并用去离子水分散固体,再离心纯化3-5次,在50-80℃恒温干燥箱中干燥。After the hydrothermal reactor is cooled to room temperature, the product is separated by centrifugation at 1200r, the supernatant is discarded, and the solid is left; and the solid is dispersed with deionized water, and then purified by centrifugation for 3-5 times, at 50-80 ℃ in a constant temperature drying oven.
作为本发明的一种优选技术方案,步骤③纯化后得到的重组胶原蛋白的纯度达到95%以上。As a preferred technical solution of the present invention, the purity of the recombinant collagen obtained after purification in step ③ reaches above 95%.
作为本发明的一种优选技术方案,步骤(2)中所述的胶原蛋白固体加入量为0.1-5mg,胶原蛋白质量分数为0.01-0.5wt%。As a preferred technical solution of the present invention, the amount of collagen solid added in step (2) is 0.1-5 mg, and the mass fraction of collagen is 0.01-0.5 wt%.
作为本发明的一种优选技术方案,步骤(2)中所述的六水合三氯化铁固体加入量为2.7-27mg,铁(III)的浓度分布从0.01到0.1mol/L。As a preferred technical solution of the present invention, the solid addition amount of ferric chloride hexahydrate described in step (2) is 2.7-27 mg, and the concentration distribution of iron (III) is from 0.01 to 0.1 mol/L.
作为本发明的一种优选技术方案,步骤(2)中所述的六水合三氯化铁和胶原蛋白混合液缓慢搅拌时间为20-50min。As a preferred technical solution of the present invention, the slow stirring time of the ferric chloride hexahydrate and collagen mixed solution described in step (2) is 20-50min.
作为本发明的一种优选技术方案,步骤(2)中所述的混合液在马弗炉内以3-10℃/min的速度升温至140-180℃,并在该温度下反应6-12hrs。As a preferred technical solution of the present invention, the mixed solution described in step (2) is heated to 140-180°C at a speed of 3-10°C/min in the muffle furnace, and reacted at this temperature for 6-12hrs .
本发明公开的一种以胶原蛋白为生物矿化模板制备Fe2O3纳米粒子的方法,具有以下优点:在整个合成过程中无需添加任何其他化学试剂或进行后处理,简单方便,易于操作,具有相当的可行性和应用价值,可为规模化生产α-Fe2O3纳米材料提供基础。A method for preparing Fe 2 O 3 nanoparticles using collagen as a biomineralization template disclosed by the present invention has the following advantages: no need to add any other chemical reagents or post-treatment during the whole synthesis process, it is simple, convenient, and easy to operate. It has considerable feasibility and application value, and can provide a basis for large-scale production of α-Fe 2 O 3 nanomaterials.
附图说明Description of drawings
图1为制备的α-Fe2O3纳米材料的粉末X射线多晶衍射(XRD)图;Fig. 1 is prepared α-Fe 2 O 3 powder X-ray polycrystalline diffraction (XRD) figure of nanometer material;
图2为制备的α-Fe2O3纳米材料的X射线光电子能谱(XPS)图;Fig. 2 is the X-ray photoelectron spectrum (XPS) figure of the prepared α-Fe 2 O 3 nanomaterials;
图3为制备的α-Fe2O3纳米材料的热重分析(TGA)图;Fig. 3 is the thermogravimetric analysis (TGA) figure of the prepared α-Fe 2 O 3 nanomaterials;
图4为制备的α-Fe2O3纳米材料的扫描电镜,透射电镜,电子衍射以及能量散射X射线分析图;Fig. 4 is the scanning electron microscope of the prepared α-Fe 2 O 3 nanomaterials, transmission electron microscope, electron diffraction and energy scattering X-ray analysis figure;
图5为不同浓度的重组胶原蛋白对α-Fe2O3纳米颗粒结构的影响;Figure 5 is the effect of different concentrations of recombinant collagen on the structure of α-Fe 2 O 3 nanoparticles;
具体实施方式detailed description
为使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解,下面结合具体实施方式,进一步阐述本发明。In order to make the technical means, creative features, goals and effects achieved by the present invention easy to understand, the present invention will be further described below in conjunction with specific embodiments.
如图1-图5所示,一种以胶原蛋白为生物矿化模板制备Fe2O3纳米粒子的方法,包括如下步骤:As shown in Figures 1-5, a method for preparing Fe2O3 nanoparticles with collagen as a biomineralization template comprises the following steps:
(1)利用生物基因工程技术制备重组胶原蛋白(1) Preparation of recombinant collagen by biogenetic engineering technology
①、确定重组胶原蛋白的序列;①. Determine the sequence of recombinant collagen;
重组胶原蛋白的序列为:The sequence of recombinant collagen is:
GSPGLPGPRGEQGPTGPTGPAGPRGLQGLQGLQGERGEQGPTGPAGPRGLQGERGEQGPTGLAGKAGEAGAKGETGPAGPQGPRGEQGPQGLPGKDGEAGAQGRPGKRGKQGQKGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGFPGERGVEGQNGQDGLPGKDGKDGQNGKDGLPGKDGKDGQNGKDGLPGKDGKDGQDGKDGLPGKDGKDGLPGKDGKDGQPGKPGKYGPPGPPGPPGPPGPPGPPGPPGPPGPPGPP,该重组胶原蛋白具备良好的三重螺旋结构,热变温度接近37℃;具有整合素的结合位点GERGFPGERGVE,可以与细胞很好的粘附;具有肝素的结合位点GRPGKRGKQGQK,可以与肝素结合;GSPGLPGPRGEQGPTGPTGPAGPRGLQGLQGLQGERGEQGPTGPAGPRGLQGERGEQGPTGLAGKAGEAGAKGETGPAGPQGPRGEQGPQGLPGKDGEAGAQGRPGKRGKQGQKGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGFPGERGVEGQNGQDGLPGKDGKDGQNGKDGLPGKDGKDGQNGKDGLPGKDGKDGQDGKDGLPGKDGKDGLPGKDGKDGQPGKPGKYGPPGPPGPPGPPGPPGPPGPPGPPGPPGPP,该重组胶原蛋白具备良好的三重螺旋结构,热变温度接近37℃;具有整合素的结合位点GERGFPGERGVE,可以与细胞很好的粘附;具有肝素的结合位点GRPGKRGKQGQK,可以与肝素结合;
②、合成编码重组胶原蛋白的核酸;②, synthesis of nucleic acid encoding recombinant collagen;
合成编码步骤①重组胶原蛋白的核酸,构建导入上述核酸的质粒,并将质粒转化大肠杆菌BL21-DE3菌株;Synthesis of coding steps ① recombining the nucleic acid of collagen, constructing a plasmid for introducing the above nucleic acid, and transforming the plasmid into Escherichia coli BL21-DE3 strain;
③、重组胶原蛋白的制备与纯化;③. Preparation and purification of recombinant collagen;
将冰冻在-80℃的大肠杆菌感受态细胞置于冰浴中融化,将感受态细胞与3-5ul质粒混合,混合体在冰浴中30min后再放入42℃水浴中90s,然后再放入冰浴中2min;在上述混合体中加入1ml不含抗生素的LB培养基,再放置于37℃恒温摇床中1hrs,然后在4℃,4000rpm条件下离心20min,弃去上层清液;使细菌在剩余培养液中重新悬浮后,将培养液均匀涂布到37℃的AMP培养平板上,置于37℃恒温摇床中过夜培养;次日挑取长势较好的菌落放入100ml含抗生素的LB液体培养基中,恒温摇床过夜进行增菌培养;将100ml过夜培养的细菌倒入1L LB培养基中,在37℃恒温摇床中继续扩增培养;待OD值达到0.8-1范围,将摇床温度调为25℃,加入1mM IPTG诱导表达,恒温过夜培养;Thaw the E. coli competent cells frozen at -80°C in an ice bath, mix the competent cells with 3-5ul plasmid, put the mixture in the ice bath for 30min, then put it in a 42°C water bath for 90s, and then put Put it in an ice bath for 2 minutes; add 1ml of LB medium without antibiotics to the above mixture, place it in a constant temperature shaker at 37°C for 1hrs, then centrifuge at 4°C and 4000rpm for 20min, discard the supernatant; After the bacteria were resuspended in the remaining culture medium, the culture medium was evenly spread on the AMP culture plate at 37°C, and placed in a constant temperature shaker at 37°C for overnight culture; the next day, pick the colony with better growth and put it into 100ml containing antibiotics In the LB liquid culture medium, carry out the enrichment culture overnight on a constant temperature shaker; pour 100ml of overnight cultured bacteria into 1L LB medium, and continue to expand and cultivate in a constant temperature shaker at 37°C; wait until the OD value reaches the range of 0.8-1 , adjust the shaker temperature to 25°C, add 1mM IPTG to induce expression, and culture overnight at constant temperature;
将上述蛋白已表达的细菌在低温离心机中离心,使菌体与培养基分离,离心条件:12000rpm,4℃,离心1.0-3.0min;将离心后的菌体用A缓冲液溶解,A缓冲液为20mM咪唑,20mM磷酸钠,0.5M氯化钠,pH为7.4;将细菌悬浊液放入超声波细胞破碎仪中进行细胞破碎,即可释放出蛋白并且蛋白会溶于A缓冲液中;超声时需将细菌悬浊液放于冰浴中,以防温度过高导致蛋白变性;将破碎完的悬浊液再次离心,使细胞碎片与蛋白溶液分离,离心条件:14000rpm,4℃,30-50min;收集上清液,此即为粗蛋白溶液;将粗蛋白过滤后,通过液相色谱进行进一步纯化;后经冻干,得到白色絮状固体;此固体放于-20℃冰箱保存,使用时通过称重法标定浓度。Centrifuge the bacteria that have expressed the above protein in a low-temperature centrifuge to separate the bacteria from the medium. Centrifugation conditions: 12000rpm, 4°C, centrifuge for 1.0-3.0min; dissolve the centrifuged bacteria with A buffer, A buffer The liquid is 20mM imidazole, 20mM sodium phosphate, 0.5M sodium chloride, and the pH is 7.4; put the bacterial suspension into an ultrasonic cell disruptor for cell disruption, and the protein can be released and the protein will be dissolved in the A buffer; During ultrasonication, the bacterial suspension should be placed in an ice bath to prevent protein denaturation caused by excessive temperature; the broken suspension should be centrifuged again to separate the cell fragments from the protein solution. Centrifugation conditions: 14000rpm, 4°C, 30 -50min; collect the supernatant, which is the crude protein solution; filter the crude protein, and further purify it by liquid chromatography; and then freeze-dry to obtain a white flocculent solid; store the solid in a -20°C refrigerator. The concentration is calibrated by weighing method when used.
(3)α-Fe2O3纳米材料的制备(3) Preparation of α-Fe 2 O 3 nanomaterials
①、重组胶原蛋白与六水合三氯化铁均匀混合溶液的配制;①. Preparation of a uniform mixed solution of recombinant collagen and ferric chloride hexahydrate;
在1ml水中加入1-50mg六水合三氯化铁和0-10mg胶原蛋白固体,混合均匀,缓慢搅拌5-90min后,得到淡黄色透明且均匀的液体;Add 1-50mg of ferric chloride hexahydrate and 0-10mg of collagen solids in 1ml of water, mix well, and stir slowly for 5-90min to obtain a light yellow transparent and uniform liquid;
②、利用水热反应釜制备纳米级α-Fe2O3;②. Preparation of nano-scale α-Fe 2 O 3 by hydrothermal reactor;
将所得混合液倒入5ml水热反应釜中,放入马弗炉内以3-18℃/min的速度升温至120-200℃,并在该温度下反应1-15hrs;Pour the resulting mixture into a 5ml hydrothermal reaction kettle, put it into a muffle furnace and raise the temperature to 120-200°C at a rate of 3-18°C/min, and react at this temperature for 1-15hrs;
③、纯化并干燥保存制备的纳米材料;③, purifying and drying the prepared nanomaterials;
待水热反应釜冷却到室温后,将产物通过离心分离,离心条件为1200r,弃去上清液,留下固体;并用去离子水分散固体,再离心纯化3-5次,在50-80℃恒温干燥箱中干燥。After the hydrothermal reactor is cooled to room temperature, the product is separated by centrifugation at 1200r, the supernatant is discarded, and the solid is left; and the solid is dispersed with deionized water, and then purified by centrifugation for 3-5 times, at 50-80 ℃ in a constant temperature drying oven.
其中,步骤③纯化后得到的重组胶原蛋白的纯度达到95%。Wherein, the purity of the recombinant collagen obtained after purification in step ③ reaches 95%.
其中,步骤(2)中所述的胶原蛋白固体加入量为1mg,胶原蛋白质量分数为0.1wt%。Wherein, the added amount of collagen solid described in step (2) is 1 mg, and the mass fraction of collagen is 0.1 wt%.
其中,步骤(2)中所述的六水合三氯化铁固体加入量为16mg,铁(III)的浓度分布从0.06mol/L。Wherein, the iron trichloride hexahydrate solid addition amount described in step (2) is 16 mg, and the concentration distribution of iron (III) is from 0.06 mol/L.
其中,步骤(2)中所述的六水合三氯化铁和胶原蛋白混合液缓慢搅拌时间为30min。Wherein, the slow stirring time of ferric chloride hexahydrate and collagen protein mixed solution described in step (2) is 30min.
其中,步骤(2)中所述的混合液在马弗炉内以5℃/min的速度升温至160℃,并在该温度下反应10hrs。Wherein, the mixed liquid described in step (2) is heated up to 160° C. at a speed of 5° C./min in the muffle furnace, and reacted at this temperature for 10 hrs.
以上所述为本发明的一个示范性实施案例的细节。对于本领域的技术人员来说,本发明在实际应用过程中根据具体的制备条件可以有各种更改和变化,并不用于限制本发明。凡在本发明的精神和原则之内,均应包含在本发明的保护范围之内,不应将权利要求中的任何附图标记视为限制所涉及的权利要求。The above is the details of an exemplary implementation case of the present invention. For those skilled in the art, the present invention may have various modifications and changes according to the specific preparation conditions in the actual application process, which are not intended to limit the present invention. Anything within the spirit and principle of the present invention shall be included in the protection scope of the present invention, and any reference signs in the claims shall not be considered as limiting the involved claims.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610458525.9A CN106115792B (en) | 2016-06-23 | 2016-06-23 | One kind preparing Fe by biomineralization template of collagen2O3The method of nano-particle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610458525.9A CN106115792B (en) | 2016-06-23 | 2016-06-23 | One kind preparing Fe by biomineralization template of collagen2O3The method of nano-particle |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106115792A true CN106115792A (en) | 2016-11-16 |
CN106115792B CN106115792B (en) | 2018-08-17 |
Family
ID=57269280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610458525.9A Active CN106115792B (en) | 2016-06-23 | 2016-06-23 | One kind preparing Fe by biomineralization template of collagen2O3The method of nano-particle |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106115792B (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106745312A (en) * | 2017-01-22 | 2017-05-31 | 泉州师范学院 | A kind of oyster shell powder area load different-grain diameter α Fe2O3The preparation method of nano composite material |
CN106835181A (en) * | 2017-02-28 | 2017-06-13 | 烟台大学 | Coli flagellum prepares iron oxide for strengthening the method that photoelectrocatalysis produces hydrogen activity for template |
CN107098396A (en) * | 2017-05-16 | 2017-08-29 | 合肥学院 | Method for controllably preparing iron oxide powder by using typha orientalis down |
CN108059184A (en) * | 2017-12-28 | 2018-05-22 | 兰州大学 | A kind of method that ZnO nanoparticle is prepared using recombined collagen as biomineralization template |
CN108358229A (en) * | 2018-03-12 | 2018-08-03 | 兰州大学 | One kind preparing micropore CaCO by biomineralization template of recombined collagen3The method of nano-particle |
CN108383147A (en) * | 2017-12-28 | 2018-08-10 | 兰州大学 | A method of preparing CuO nano-particles by biomineralization template of recombined collagen |
CN108404220A (en) * | 2017-12-28 | 2018-08-17 | 兰州大学 | A kind of biodegradable aqueogel and preparation method thereof |
CN109231484A (en) * | 2018-09-30 | 2019-01-18 | 中南大学 | The method of organic matter collaboration microbiological treatment waste water containing trivalent arsenic |
CN111604094A (en) * | 2020-01-14 | 2020-09-01 | 武汉理工大学 | Escherichia coli mixed iron oxide nanomaterial and its biomimetic mineralization method and application |
CN111606325A (en) * | 2020-06-12 | 2020-09-01 | 东华大学 | A kind of preparation method of graphene-iron oxide nano-functional child with wave-absorbing function |
CN113456826A (en) * | 2021-06-04 | 2021-10-01 | 华侨大学 | Multi-responsiveness magnetic nano material and preparation method thereof |
CN113520899A (en) * | 2021-03-25 | 2021-10-22 | 甘肃天际生物科技有限公司 | Recombinant collagen product for skin photodamage repair |
CN113889346A (en) * | 2021-09-29 | 2022-01-04 | 甘肃天际生物科技有限公司 | collagen-gamma-MnO2Composite nano material and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101041470A (en) * | 2007-03-23 | 2007-09-26 | 清华大学 | Method for synthesizing block-shaped alpha-ferric oxide nanostructure |
CN102649589A (en) * | 2012-05-24 | 2012-08-29 | 复旦大学 | Fibroin-controlled alpha type ferric oxide nano material and preparation method thereof |
CN105236495A (en) * | 2015-09-15 | 2016-01-13 | 中南大学 | A method for preparing shape-controllable α-Fe2O3 mesoscopic crystals using protein as a template |
-
2016
- 2016-06-23 CN CN201610458525.9A patent/CN106115792B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101041470A (en) * | 2007-03-23 | 2007-09-26 | 清华大学 | Method for synthesizing block-shaped alpha-ferric oxide nanostructure |
CN102649589A (en) * | 2012-05-24 | 2012-08-29 | 复旦大学 | Fibroin-controlled alpha type ferric oxide nano material and preparation method thereof |
CN105236495A (en) * | 2015-09-15 | 2016-01-13 | 中南大学 | A method for preparing shape-controllable α-Fe2O3 mesoscopic crystals using protein as a template |
Non-Patent Citations (2)
Title |
---|
LI CAI ET AL: "Using Collagen Fiber as a Template to Synthesize TiO2 and Fex/TiO2 Nanofibers and Their Catalytic Behaviors on the Visible Light-Assisted Degradation of Orange II", 《INDUSTRIAL & ENIGEERING CHEMISTRY RESEARCH》 * |
盛卫琴: "丝蛋白纳米纤维调控合成纳米氧化铁及其机理研究", 《中国博士学位论文全文数据库工程科技Ⅰ辑》 * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106745312A (en) * | 2017-01-22 | 2017-05-31 | 泉州师范学院 | A kind of oyster shell powder area load different-grain diameter α Fe2O3The preparation method of nano composite material |
CN106745312B (en) * | 2017-01-22 | 2020-06-30 | 泉州师范学院 | Oyster shell powder surface loading α -Fe with different particle sizes2O3Process for preparing nano composite material |
CN106835181A (en) * | 2017-02-28 | 2017-06-13 | 烟台大学 | Coli flagellum prepares iron oxide for strengthening the method that photoelectrocatalysis produces hydrogen activity for template |
CN106835181B (en) * | 2017-02-28 | 2018-08-14 | 烟台大学 | Coli flagellum is the method that template prepares that iron oxide produces hydrogen activity for enhancing photoelectrocatalysis |
CN107098396A (en) * | 2017-05-16 | 2017-08-29 | 合肥学院 | Method for controllably preparing iron oxide powder by using typha orientalis down |
CN108059184B (en) * | 2017-12-28 | 2020-10-27 | 兰州大学 | A method for preparing ZnO nanoparticles using recombinant collagen as biomineralization template |
CN108059184A (en) * | 2017-12-28 | 2018-05-22 | 兰州大学 | A kind of method that ZnO nanoparticle is prepared using recombined collagen as biomineralization template |
CN108383147A (en) * | 2017-12-28 | 2018-08-10 | 兰州大学 | A method of preparing CuO nano-particles by biomineralization template of recombined collagen |
CN108404220A (en) * | 2017-12-28 | 2018-08-17 | 兰州大学 | A kind of biodegradable aqueogel and preparation method thereof |
CN108383147B (en) * | 2017-12-28 | 2020-10-27 | 兰州大学 | A method for preparing CuO nanoparticles using recombinant collagen as biomineralization template |
CN108358229A (en) * | 2018-03-12 | 2018-08-03 | 兰州大学 | One kind preparing micropore CaCO by biomineralization template of recombined collagen3The method of nano-particle |
CN109231484A (en) * | 2018-09-30 | 2019-01-18 | 中南大学 | The method of organic matter collaboration microbiological treatment waste water containing trivalent arsenic |
CN111604094A (en) * | 2020-01-14 | 2020-09-01 | 武汉理工大学 | Escherichia coli mixed iron oxide nanomaterial and its biomimetic mineralization method and application |
CN111604094B (en) * | 2020-01-14 | 2021-11-02 | 武汉理工大学 | Escherichia coli mixed iron oxide nanomaterial and its biomimetic mineralization method and application |
CN111606325A (en) * | 2020-06-12 | 2020-09-01 | 东华大学 | A kind of preparation method of graphene-iron oxide nano-functional child with wave-absorbing function |
CN113520899A (en) * | 2021-03-25 | 2021-10-22 | 甘肃天际生物科技有限公司 | Recombinant collagen product for skin photodamage repair |
CN113456826A (en) * | 2021-06-04 | 2021-10-01 | 华侨大学 | Multi-responsiveness magnetic nano material and preparation method thereof |
CN113889346A (en) * | 2021-09-29 | 2022-01-04 | 甘肃天际生物科技有限公司 | collagen-gamma-MnO2Composite nano material and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106115792B (en) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106115792A (en) | A method for preparing Fe2O3 nanoparticles with collagen as biomineralization template | |
CN103420364B (en) | A kind of preparation method of grapheme/hydroxyapatcomposite composite material | |
Kar et al. | Synthesis and characterization of Cu/Ag nanoparticle loaded mullite nanocomposite system: A potential candidate for antimicrobial and therapeutic applications | |
Zhang et al. | A novel composite scaffold comprising ultralong hydroxyapatite microtubes and chitosan: preparation and application in drug delivery | |
JP2007523096A (en) | Metal complex solution and its application | |
CN103783080B (en) | Antibacterial activity carbon nanometer composite material and preparation method thereof | |
CN101297978A (en) | Preparation method of hydroxyapatite nano pole | |
CN104872082B (en) | A kind of nano zine oxide for preparing high-performance silk freshens food and educates silkworm method and its product | |
CN105294070B (en) | A kind of method for preparing anti-bacteria ceramic | |
CN101704536A (en) | Novel Prussian blue mesocrystals and preparation method thereof | |
CN104415399A (en) | Hydroxyapatite/graphene nano-composite powder and preparation method thereof | |
CN105272377A (en) | Preparation method of antibacterial ceramic | |
CN105126160A (en) | Hydroxyapatite scaffold material with graphene-modified surface and preparation method of hydroxyapatite scaffold material | |
CN114532333B (en) | Method for constructing attapulgite-zinc oxide nano composite antibacterial material by using liquorice extract | |
Li et al. | Conversion of Calcined Eggshells into Flower‐Like Hydroxyapatite Agglomerates by Solvothermal Method Using Hydrogen Peroxide/N, N‐Dimethylformamide Mixed Solvents | |
CN108383147A (en) | A method of preparing CuO nano-particles by biomineralization template of recombined collagen | |
CN108102433B (en) | Method for preparing high-thermal stability clay mineral-iron red hybrid pigment by utilizing coprecipitation technology | |
CN108059184B (en) | A method for preparing ZnO nanoparticles using recombinant collagen as biomineralization template | |
CN105315353B (en) | It is a kind of to utilize titanium dioxide powder of surface display foreign protein synthesis and its preparation method and application | |
CN105347972A (en) | Composting method using mesoporous silica as heavy metal passivator and microbial carrier | |
CN107473269A (en) | The preparation method and application of ceria attapulgite ferroferric oxide magnetic nano composite | |
CN114532332B (en) | Method for constructing zinc oxide/attapulgite nano composite antibacterial material by utilizing ginkgo leaf extract | |
CN109370963A (en) | A kind of cultural method of colibacillus engineering high efficient expression supercoiled plasmid DNA | |
CN103752300A (en) | Antibacterial activated carbon composite material and preparation method thereof | |
CN108358229A (en) | One kind preparing micropore CaCO by biomineralization template of recombined collagen3The method of nano-particle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201118 Address after: 730030 No.888 Yanchang Road Street, Chengguan District, Lanzhou City, Gansu Province Patentee after: Lanzhou Biological Technology Development Co.,Ltd. Address before: 730030 No. 222 Tianshui North Road, Gansu, Lanzhou Patentee before: LANZHOU University |